Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Hospital Virgen de las Nieves clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Spain register with University Hospital Virgen de las Nieves as lead sponsor. Synced 24 Oct 2026
3Current trials
1Recruiting now
1Drug in these trials
1Trial register
At a glance

University Hospital Virgen de las Nieves is the lead sponsor of 3 current clinical trials in our Spain register. 1 is recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Diclofenac. The most-studied condition is Colorectal Polyps.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open133%
  • Active, closed133%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by University Hospital Virgen de las Nieves

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
White Light, TXI, NBI and Computer-Aided Detection for Recurrence at Post-EMR Scars (PRINCESS)
NCT07874152 · ClinicalTrials.gov ↗ · Colorectal Polyps
Not applicable Recruiting 2024-12 Spain
Cold Water Papillary Irrigation Plus Rectal NSAIDs vs Rectal NSAIDs Alone for Post-ERCP Pancreatitis (COLD)
NCT07885852 · ClinicalTrials.gov ↗ · Post ERCP Pancreatitis, Acute Pancreatitis (AP)
Not applicable Not yet open 2026-11 Spain
A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV
NCT06518408 · ClinicalTrials.gov ↗ · Human Immunodeficiency Virus
Observational Active, closed 2023-06 Spain

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University Hospital Virgen de las Nieves trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University Hospital Virgen de las Nieves trials

4 conditions
Colorectal Polyps1Human Immunodeficiency Virus1Post ERCP Pancreatitis1Acute Pancreatitis (AP)1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Spain31

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Colorectal Polyps

SponsorTrials
i+Med S.Coop1

Sponsors with the most current trials registered for this condition.

06

Questions about University Hospital Virgen de las Nieves trials

How many clinical trials does University Hospital Virgen de las Nieves sponsor?

University Hospital Virgen de las Nieves is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Spain register, as of the registry sync on 24 October 2026. Completed and withdrawn studies are not counted.

Are University Hospital Virgen de las Nieves trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University Hospital Virgen de las Nieves testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Diclofenac (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 24 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.